Daiwa Securities Group Inc. Has $2.35 Million Stake in Colgate-Palmolive (CL)

Daiwa Securities Group Inc. lifted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 5.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,131 shares of the company’s stock after buying an additional 1,706 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Colgate-Palmolive were worth $2,352,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Welch Group LLC lifted its stake in Colgate-Palmolive by 7.2% in the third quarter. Welch Group LLC now owns 355,417 shares of the company’s stock valued at $23,795,000 after buying an additional 23,750 shares in the last quarter. Mondrian Investment Partners LTD bought a new position in Colgate-Palmolive in the third quarter valued at approximately $31,331,000. Private Advisor Group LLC lifted its stake in Colgate-Palmolive by 38.6% in the third quarter. Private Advisor Group LLC now owns 40,849 shares of the company’s stock valued at $2,735,000 after buying an additional 11,378 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in Colgate-Palmolive by 4.6% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 48,134 shares of the company’s stock valued at $3,223,000 after buying an additional 2,137 shares in the last quarter. Finally, Willingdon Wealth Management lifted its stake in Colgate-Palmolive by 8.2% in the third quarter. Willingdon Wealth Management now owns 39,803 shares of the company’s stock valued at $2,665,000 after buying an additional 3,033 shares in the last quarter. 75.08% of the stock is currently owned by institutional investors and hedge funds.

A number of research analysts have weighed in on the stock. Stifel Nicolaus cut their price target on shares of Colgate-Palmolive from $75.00 to $73.00 and set a “hold” rating on the stock in a research note on Monday, July 23rd. Wells Fargo & Co cut their price target on shares of Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating on the stock in a research note on Wednesday, October 17th. Argus cut their price target on shares of Colgate-Palmolive from $75.00 to $70.00 and set a “buy” rating on the stock in a research note on Tuesday, October 30th. ValuEngine raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research note on Tuesday, July 31st. Finally, Morgan Stanley cut their price target on shares of Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating on the stock in a research note on Tuesday, October 30th. Four investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $68.06.

In related news, VP Philip G. Shotts sold 17,000 shares of the business’s stock in a transaction on Tuesday, August 14th. The shares were sold at an average price of $65.44, for a total transaction of $1,112,480.00. Following the transaction, the vice president now directly owns 49,949 shares in the company, valued at $3,268,662.56. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Vice Chairman Dennis J. Hickey sold 120,000 shares of the business’s stock in a transaction on Tuesday, August 14th. The stock was sold at an average price of $65.72, for a total transaction of $7,886,400.00. Following the transaction, the insider now owns 202,414 shares in the company, valued at $13,302,648.08. The disclosure for this sale can be found here. Insiders sold 149,811 shares of company stock worth $9,835,756 over the last quarter. 1.02% of the stock is owned by corporate insiders.

NYSE CL opened at $63.80 on Friday. The company has a debt-to-equity ratio of 64.85, a quick ratio of 0.77 and a current ratio of 1.11. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $77.91. The company has a market capitalization of $53.19 billion, a PE ratio of 20.58, a price-to-earnings-growth ratio of 3.01 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 26th. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The company had revenue of $3.85 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same period last year, the company earned $0.73 earnings per share. The firm’s revenue was down 3.2% compared to the same quarter last year. On average, analysts predict that Colgate-Palmolive will post 2.96 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 15th. Stockholders of record on Friday, October 19th will be issued a $0.42 dividend. The ex-dividend date of this dividend is Thursday, October 18th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.63%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.54%.

TRADEMARK VIOLATION NOTICE: This piece was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/11/10/daiwa-securities-group-inc-has-2-35-million-stake-in-colgate-palmolive-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Recommended Story: How can you know how many shares are floating?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply